期刊文献+

PET/CT确定非小细胞肺癌三维适形放疗靶区的临床研究 被引量:1

Clinical study of PET/CT on delineation of the target volume for conformal radiation therapy in non - small -cell lung cancer
下载PDF
导出
摘要 目的探讨PET—CT检查对非小细胞肺癌(non—small—cell lung cancer,NSCLC)患者的分期与治疗方案的影响和PET/CT所确定的靶区(GTV)与病理学肿瘤大小的关系。方法2006年3月一2008年7月间37例接受手术或放疗的NSCLC患者,根据PET/CT检查结果,21例患者进入手术组(有手术指征),16例患者进入放疗组(无手术指征),手术组术前在PET/CT图像上确定肿瘤在冠状轴(x轴)、矢状轴(Y轴)、长轴(z轴)三维径线上的大小,术后病理检查,确定肿瘤在X、Y、Z轴上的大小;TNM分期分别用CT、PET/CT分期与病理学分期。放疗组分别在PET/CT和CT横断图像上勾画原发灶和纵隔淋巴结GTV,软件自动运算PET/CT和模拟定位增强CT所勾画靶区的体积。结果19例(51.4%)的TNM分期在PET/CT检查后发生改变;12例(37.8%)的治疗方案因而发生变化。CT、PET/CT、病理确定的原发灶大小在X、Y轴上无显著差异(P值〉0.05),Z轴上有显著差异(P值〈0.05);放疗组16例患者中,PET/CT所勾画的GTVPET〉GTVCT者共4例,因为PET/CT发现不符合CT诊断标准的纵隔淋巴结转移灶。GTVPET〈GTVCT者共7例,主要是因为PET/CT排除了阻塞性肺炎和肺不张。结论PET/CT检查对分期与治疗方案的影响较大,PET/CT与病理学的肿瘤大小基本一致,PET/CT所确定的肿瘤大小可以作为病理学的GTV,勾画非小细胞肺癌放疗靶区PET/CT优于CT。 Objective To evaluate the influence to stage and the treatment planning in non -small cell lung cancer(NSCLC) by CT,PET/CT. To define the correlation of gross tumor volume(GTV) by PET/CT and pathology. Methods From March 2006 to July 2008,37 NSCLC patients were studied,21 cases received surgical resection and 16 cases received radiotherapy based on PET/CT. All patients had PET/CT scans of all body before surgery or radiotherapy and routine pathology examination after surgery. The tumor size at X( lateral direction) ,Y (ventrodorsal direction)and Z( craniocaudal direction)axes were measured on CT,PET/CT and pathology exami- nation, respectively. TNM stage change the treatment planning in a significant number of patients, both the CT and PET/CT images were transferred to the RT planning workstation for contouring. GTV, pathologic nodal and prima- ry tumor volumes were first defined in the conventional manner based on CT and PET/CT images. Results TNM stage was changed in 19 cases(51.4% )and the treatment planning was changed in 12 cases(37.8% )after PET/ CT. There was no significant difference in the tumor size at X , Y axes ( P 〉 0.05 ) ; and there was significant difference in the tumor size at Z axes. Of the 16 patients in radiotherapy group, the primary tumor GTV was increased in 4 cases by detecting additional nodal disease burden, and decreased GTV in 7 cases by differentiating atelectasis and postobstructive pneumonia from tumor. Conclusions PET/CT alter TNM stage and the treatment planning in NSCLC in a significant number of patients, there was almost total agreement on the gross tumor volume by PET/CT and pathology. GTV could be used for radiation therapy by PET/CT instead of the GTV by pathology. PET/CT is superior CT on delineation of the gross tumor volume for radiation planning.
出处 《实用肿瘤学杂志》 CAS 2011年第1期29-32,共4页 Practical Oncology Journal
基金 2006年佛山市科委课题项目(200608029)
关键词 肺肿瘤 非小细胞肺癌 病理学 正电子发射体层显像 靶区 Lung neoplasms Non - small cell lung cancer Pathology 18FFDG - PET/CT Grosstumor volume
  • 相关文献

参考文献10

  • 1周菊英,王利利,蔡晓君,郭建,秦颂兵,徐晓婷,李莉,俞志英.PET/CT对非小细胞肺癌精确放疗计划的影响[J].核技术,2010,33(1):75-78. 被引量:13
  • 2Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography [J]. N Engl J Med, 2003,348 (25) :2500-2507.
  • 3李万龙,于金明,刘国华,仲伟霞,李文武,张百江.非小细胞肺癌影像学与病理学靶区关系的研究[J].中华肿瘤杂志,2003,25(6):566-568. 被引量:39
  • 4Nestle U, Kremp S, Schaefer-Schuler A, et al. Comparison of different methods for delineation of is F-FDG PET-pos-itive tissue for target volume definition in radiotherapy of pa- tients with non-small cell lung cancer [J]. J Nucl Med, 2005,46 (8) : 1342-1348.
  • 5Carlo G, Kenneth R, Giuseppe LC, et al. Current status of PET/CT for tumour volume definition in radiotherapy treat-ment planning for non-small cell lung cancer (NSCLC) [J]. Lung Cancer,2007,57(2) : 125-134.
  • 6Davis JB, Reiner B, Huser M, et al. Assessment of is F-PET signals for automatic target volume definition in radiotherapy treatment planning[J]. Radiother Oncol,2006,80( 1 ) :43-50.
  • 7Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer[J]. Int J Radiat Oneol Biol Phys,2004, 59(1) :78-86.
  • 8Farias L, Menard S, Devic S, et al. Impact of FDG - PET/ CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic fingings [J]. Int J Radiat Oneol Biol Phys, 2008,70 (4) : 1035-1038.
  • 9Vila A, S6nchez-Reyes A, Conill C, et al. Comparison of positron emission tomography (PET)and computed tomo-graphy(CT) for better target volume deft nition in radiation therapy planning [J]. Clin Transl Oncol, 2010,12 (5) : 367-373.
  • 10Xing L, Wessels B. The value of PET/CT is being over-sold as a clinical tool in radiation oncology [J]. Med Phys, 2005,32(6) :1457-1459.

二级参考文献2

共引文献50

同被引文献45

  • 1李承军,徐利明.肺癌放疗中活动靶区常规CT定位和PET/CT定位的模体研究比较[J].中国医学物理学杂志,2011,28(4):2743-2749. 被引量:8
  • 2王学涛,于金明,杨国仁,巩合义.PET-CT同机融合精度验证及在放疗靶区勾画中的应用[J].中华放射肿瘤学杂志,2005,14(3):204-207. 被引量:13
  • 3夏廷毅.γ(X)-线立体定向放射治疗临床应用规范和治疗进展[J].中国癌症杂志,2006,16(6):454-458. 被引量:38
  • 4Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statis- tics, 2005. CA Cancer ] Clin 2005; 55:10-30 [PMID: 15661684 DOI: 10.3322/canjclin.55.1.10].
  • 5Jemal A, Bray F, Center MM, Ferlay J, Ward E, For- man D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90 [PMID: 21296855 DOI: 10.3322/ caac.20107].
  • 6Ernst-Stecken A, Lambrecht U, Mueller R, Sauer R, Grabenbauer G. Hypofractionated stereotactic radiotherapy for primary and secondary intra- pulmonary tumors: first results of a phase I/II study. Strahlenther Onkol 2006; 182:696-702 [PMID: 17149575].
  • 7Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J. Results of a phase I dose-escalation study using single-fraction stereotactic radiothera- py for lung tumors. J Thorac Oncol 2006; 1:802-809 [PMID: 17409963].
  • 8Rusthoven KE, Hammerman SF, Kavanagh BD, Birtwhistle MJ, Stares M, Camidge DR. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analy- sis. Acta Oncol 2009; 48:578-583 [PMID: 19373699 DOI: 10.1080/02841860802662722].
  • 9Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gas- par LE, Schefter TE. Multi-institutional phase Ⅰ/Ⅱ trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009; 27:1579-1584 [PMID: 19255320 DOI: 10.1200/JCO.2008.19.6386].
  • 10Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Multi- institutional phase Ⅰ/Ⅱ trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009; 27:1572-1578 [PMID: 19255321 DOI: 10.1200/ JCO.2008.19.6329].

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部